158th SICTIC Investor Day @ Balgrist University Hospital, Zurich
Startups on stage
-
Altiscreen
Altiscreen builds a handheld drug screening device to help polices detect drug of abuse with its A1 plateform technology.
-
Avrion Therapeutics
Avrion Therapeutics develops therapeutics to protect synapses as a new way to treat neurodegenerative disorders.
-
BigOmics Analytics SA
We are the creators of Omics Playground, a self-service analytics platform that empowers biologists to perform complex analysis and visualisation by themselves
-
dEEGtal
We build a Large Brain Model that finally decodes the brain, first powering our clinical platform for epilepsy care.
-
EchoRapp
The cardiology intelligence layer for echocardiography.
-
Hemetron AG
Transforming chronic care from episodic centralized interventions to remote disease management via at-home monitoring
-
MPC Therapeutics
MPC Therapeutics develops small molecules reversing ageing by targeting mitochondria, the cell's powerhouse.
-
Precise Health
We make antibiotics more effective through Al and genomics to enable clinicians to treat resistant infections 10× faster.
-
rayne care
Rayne produces a patented, Swiss-made menstrual disc, a gateway to women's health via period blood analysis.
-
RELiYOO
RELiYOO offers disruptive seating solutions for wheelchair users, preventing pressure sores with intelligent cushions.
-
Scanvio Medical
Scanvio Medical is developing AI-powered real-time guidance for ultrasound to help gynecologists diagnose endometriosis.
-
Swibrace
Swibrace develops patient-specific medical devices using 3D scanning, automated design and additive manufacturing.
-
Versive
Versive is bringing integrated steering to manual wheelchairs to reduce energy loss and enhance everyday mobility.
Event Agenda
16:30 – Registration (On-Site Attendees)
17:00 – Welcome & Intro from SICTIC
17:10 – Intro from Balgrist University Hospital
17:20 – Keynote by Dr. Greta Preatoni, CEO & Co-founder, MYNERVA
17:40 – 90s Startup Pitches
18:00 – Short Break
18:15 – Keynote by VISCHER
18:25 – 5 min Startup Pitching Session + Q&A
19:15 – AFR Pitches + Investor Pitches + Q&A
19:45 – Wrap up by SICTIC
19:50 – Networking Apéro / Livestream ends
21:00 – Event ends
Speakers

Dr. Greta Preatoni
CEO & Co-founder at MYNERVA
As a neuroengineering Ph.D. graduate from ETH Zürich, Greta has a passion for applying cutting-edge research to real-world problems. That’s why she co-founded MYNERVA, a startup that develops a groundbreaking device for the treatment of diabetic neuropathy, a chronic and debilitating condition that affects millions of people worldwide.

Barbara Meier LL.M.
Attorney at Law, Managing Associate at VISCHER
Barbara Meier is an attorney at law and Managing Associate in VISCHER’s Regulated Markets practice teams. She regularly advises domestic and international companies on regulatory compliance, health care, and life sciences matters, including medical device regulations and reimbursement questions. Barbara holds an LL.M. from Duke University and a Master’s Degree from the University of Zurich.

Dr. Joel Drittenbass
Attorney at Law, Senior Associate at VISCHER
Dr. Joel Drittenbass is an attorney at law and Senior Associate at VISCHER, specialising in public sector, healthcare, and regulatory law as well as emerging technologies. His academic research at the University of St. Gallen (HSG) focused on medical device law and data protection in autonomous systems, for which he was awarded the Walther Hug Prize. He lectures on constitutional and administrative law at the University of St. Gallen.
Registration
Startup Applications
Startups: If you want to pitch, please submit your project here. If accepted to pitch, you will get two free tickets to attend. We encourage startups that fulfil our investment criteria to submit their business case. We offer this service and the pitching at one of our events free of charge to startups. For each SICTIC Investor Day, a jury will select the eight most promising startups for pitching at the event.
Important: In case you don’t express your interest to pitch at an event in your application form, we will assume you would rather just to want share your business case with SICTIC members and investors and will not include your project in the selection process.
Investor Registration
This event is intended primarily for angel investors (also novices). Family offices, fund managers and venture capitalists that want to invest in Swiss Startups are also welcome to attend.
SICTIC Investors and invited guests please use your promotion code to get your free ticket.
Investors: You can read the startup business cases before the event by joining our SICTIC Investor Community. You can then attend SICTIC Investor Days for free and get access to our online deal platform.
Limited seating. No entry without a valid ticket. No ticket sale at the event.